XML 45 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
Equity
12 Months Ended
Dec. 31, 2018
Share-Based Payment Arrangements [Abstract]  
Equity
Equity:
Share-based Compensation
December 31, 2018

 
December 31, 2017

Option Expense
$
1,676

 
$
1,245

DSU Expense for 2018
307

 
679

DSU Expense Adjustment for 2017
(45
)
 

RSU Expense
964

 
1,201

Total Share-based Compensation (included in net loss)
$
2,902

 
$
3,125

2017 DSU Expense (issued in 2018) (note 20 (e))
380

 
(380
)
Total Share-based Compensation (per statement of equity)
$
3,282

 
$
2,745


(a)
Share capital:
Authorized and issued:
Unlimited number of common shares, voting, without par value.
Unlimited number of preferred shares, issuable in series.
Private placement:
On November 13, 2018, the Corporation closed a private placement strategic equity investment with Weichai Power of 46,131,712 common shares and with Broad-Ocean Motor Co., Ltd. (a current strategic investor) of a further 5,699,947 common shares issued from treasury at $3.5464 per share for gross proceeds of $163,602,000 and $20,214,000, respectively.
Gross Offering proceeds (51,831,659 shares at $3.5464 per share)
$
183,816

Less: Share issuance costs
(144
)
Net Offering proceeds
$
183,672


20.
Equity (cont'd):
(b)
Share Purchase Warrants:
 
Exercise price of

 
Exercise price of

 
Total

Warrants Outstanding
$
1.50

 
$
2.00

 
Warrants

At January 1, 2017
122,563

 
1,675,000

 
1,797,563

Warrants exercised in 2017

 
(1,012,500
)
 
(1,012,500
)
At December 31, 2017
122,563

 
662,500

 
785,063

Warrants exercised in 2018
(122,563
)
 
(625,000
)
 
(747,563
)
Warrants expired in 2018


(37,500
)
 
(37,500
)
At December 31, 2018

 

 


During 2018, 747,563 (2017 - 1,012,500) warrants were exercised for an equal amount of common shares for net proceeds of $1,434,000 (2017 - $2,025,000).
At December 31, 2018, no share purchase warrants were issued and outstanding (2017785,063).
(c)
Share options:
The Corporation has options outstanding under a consolidated share option plan. All directors, officers and employees of the Corporation, and its subsidiaries, are eligible to participate in the share option plans although as a matter of policy, options are currently not issued to directors. Option exercise prices are denominated in either Canadian or U.S. dollars, depending on the residency of the recipient. Canadian dollar denominated options have been converted to U.S. dollars using the year-end exchange rate for presentation purposes.
All options have a term of seven years from the date of grant unless otherwise determined by the board of directors. One-third of the options vest and may be exercised, at the beginning of each of the second, third, and fourth years after granting.
As at December 31, options outstanding from the consolidated share option plan were as follows:
Balance
Options for common shares

 
Weighted average exercise price

At January 1, 2017
5,537,729

 
$
1.84

Options granted
1,498,776

 
2.21

Options exercised
(1,820,193
)
 
1.99

Options forfeited
(277,839
)
 
1.91

Options expired
(110,300
)
 
2.31

At December 31, 2017
4,828,173

 
2.01

Options granted
1,675,640

 
3.27

Options exercised
(945,022
)
 
1.66

Options forfeited
(400,663
)
 
2.22

Options expired
(24,667
)
 
1.35

At December 31, 2018
5,133,461

 
$
2.34


20.
Equity (cont'd):
(c)
Share options (cont'd):
The following table summarizes information about the Corporation’s share options outstanding as at December 31, 2018:
 
Options outstanding
 
Options exercisable
 
Number

 
Weighted average
remaining
contractual life
 
Weighted
average
exercise

 
Number

 
Weighted
average

Range of exercise price
outstanding

 
(years)
 
price

 
exercisable

 
exercise price

$0.83 - $1.19
208,167

 
1.2
 
$
0.90

 
208,167

 
$
0.90

$1.23 - $1.96
1,689,154

 
4.6
 
1.64

 
736,818

 
1.51

$2.00 - $2.74
1,994,924

 
3.9
 
2.39

 
1,441,920

 
2.32

$2.80 - $3.74
1,241,216

 
6.0
 
3.48

 
68,190

 
3.21

 
5,133,461

 
4.5
 
$
2.34

 
2,455,095

 
$
1.98


During 2018, 945,022 options were exercised for an equal amount of common shares for proceeds of $1,628,000. During 2017, 1,820,193 options were exercised for an equal amount of common shares for proceeds of $3,598,000 .
During 2018, options to purchase 1,675,640 common shares were granted with a weighted average fair value of $1.70 (20171,498,776 options and $1.09 fair value). The granted options vest annually over three years.
The fair values of the options granted were determined using the Black-Scholes valuation model under the following weighted average assumptions:
 
2018

 
2017

Expected life
4 years

 
4 years

Expected dividends
Nil

 
Nil

Expected volatility
64
%
 
70
%
Risk-free interest rate
2
%
 
1
%

As at December 31, 2018, options to purchase 5,133,461 common shares were outstanding (20174,828,173). During 2018, compensation expense of $1,676,000 (2017$1,245,000) was recorded in net loss based on the grant date fair value of the awards recognized over the vesting period.
(d)
Share distribution plan:
The Corporation has a consolidated share distribution plan that permits the issuance of common shares for no cash consideration to employees of the Corporation to recognize their past contribution and to encourage future contribution to the Corporation. At December 31, 2018, there were 12,051,923 (201711,617,902) shares available to be issued under this plan.
During 2017 and 2018, no shares were issued under this plan and therefore no compensation expense was recorded against income.
(e)
Deferred share units:
Deferred share units (“DSUs”) are granted to the board of directors and executives. Eligible directors must elect to receive at least half of their annual retainers and executives may elect to receive all or part of their annual bonuses in DSUs. Each DSU is redeemable for one common share in the capital of the Corporation after the director or executive ceases to provide services to the Corporation. Shares will be issued from the Corporation’s share distribution plan.

20.
Equity (cont'd):
(e)
Deferred share units (cont'd):
Balance
DSUs for common shares

At January 1, 2017
1,125,250

DSUs granted
87,682

DSUs exercised
(347,588
)
At December 31, 2017
865,344

DSUs granted
179,469

DSUs exercised
(297,600
)
At December 31, 2018
747,213


During 2018, $307,000 of compensation expense was recorded in net loss relating to 91,361 DSUs granted during the year. For the remaining 88,108 DSUs granted during the year, estimated compensation expense of $380,000 was recorded in net income in 2017. Upon the issuance of the DSUs in 2018, a $45,000 adjustment increasing net income was recorded.
During 2017, $679,000 of compensation expense was recorded in net loss, of which $299,000 related to DSUs granted during the year. The remaining $380,000 related to compensation expense recorded in 2017 for DSUs ultimately issued in 2018.
During 2018, 297,600 DSUs (2017347,588) were exercised, net of applicable taxes, which resulted in the issuance of 154,752 common shares (2017181,788).
As at December 31, 2018, 747,213 deferred share units were outstanding (2017865,344).
(f)
Restricted share units:
Restricted share units (“RSUs”) are granted to employees and executives. Each RSU is convertible into one common share. The RSUs vest after a specified number of years from the date of issuance, and under certain circumstances, are contingent on achieving specified performance criteria. A performance factor adjustment is made if there is an over-achievement of specified performance criteria, resulting in additional RSUs being converted and likewise if there is an under-achievement of specified performance criteria, a lower number of RSUs will be converted.
The Corporation has two plans under which RSUs may be granted, the consolidated share distribution plan and the market purchase RSU plan. Awards under the consolidated share distribution plan (note 20(d)) are satisfied by the issuance of treasury shares on maturity. Awards granted under the market purchase RSU Plan are satisfied by shares purchased on the open market by a trust established for that purpose. No common shares were repurchased in 2018 and 2017.
 
RSUs for common shares

At January 1, 2017
1,473,408

RSUs granted
735,978

RSU performance factor adjustment
186,083

RSUs exercised
(560,677
)
RSUs forfeited
(160,155
)
At December 31, 2017
1,674,637

RSUs granted
379,257

RSU performance factor adjustment
218,213

RSUs exercised
(290,820
)
RSUs forfeited
(203,095
)
At December 31, 2018
1,778,192


20.
Equity (cont'd):
(f)
Restricted share units (cont'd):
During 2018, 379,257 RSUs were issued (2017735,978). The fair value of RSU grants is measured based on the stock price of the shares underlying the RSU on the date of grant. During 2018, compensation expense of $964,000 (2017 - $1,201,000) was recorded in net loss.
During 2018, 290,820 RSUs (2017560,677) were exercised, net of applicable taxes, which resulted in the issuance of 149,980 common shares (2017298,556).
As at December 31, 2018, 1,778,192 RSUs were outstanding (20171,674,637).